3 Times Square
New York, NY
Add to Your Calendar
On Tuesday, October 14, Christina Schwarz will speak on the panel “Exploring New Litigation Concerns from Amneal and The FTC’s Latest Call for Orange Book Delistings” at ACI’s Inaugural Summit on Pharma & Biotech Patent Litigation USA in NYC on October 14 – 15. The panel will examine how the recent Teva v. Amneal ruling will impact Orange Book patents and Hatch-Waxman litigation. Venable is sponsoring the summit.
You can learn more about the conference here.